Epibase^® optimizes your vaccine development efforts at research level and throughout the vaccine design cycle.

Maximize the population response to your vaccines
Epibase^® screens for epitopes throughout a broad subset of HLA’s, addressing a very broad population. Currently, the plaform address all major HLA types for Caucasian and Oriental population groups.

Select the optimal strains and protein domains
Epibase^® assists your vaccine development process by identifying those proteins and protein domains that are the most antigenic, immunogenic and/or effective. It also helps in selecting the strains and variants showing the highest T-cell response.

Build new IP
Epibase^® has the intrinsic capacity to identify epitopes that will not be recognized by learning based tools because of atypical sequence motifs.

Analyze the promiscuity of your epitopes
Epibase profiles allow to select those epitopes that are recognized by a broad range of HLAs.

Assess the cytotoxic and T-helper immunogenicity of
vaccine leads
Epibase^® builds the epitope profiles for both Class-I and Class-II response.